Biotech · Private company
Senseonics, Inc.
Track this companyFree. Adds Senseonics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials73 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- Blood glucose meterDiabetesClinicalTrials.gov · fetched Nov 12, 2026
- Continuous Glucose Monitoring SystemDiabetesClinicalTrials.gov · fetched Nov 12, 2026
- Continuous Glucose Monitoring SystemDiabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- Eversense CGM SystemDiabetesClinicalTrials.gov · fetched Nov 12, 2026
- Eversense® CGM SystemDiabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- ROME GS System StudyNA · RECRUITING · started Feb 12, 2026ClinicalTrials.gov NCT07518004 · fetched Nov 12, 2026
- Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement FeatureNA · RECRUITING · started Dec 29, 2025ClinicalTrials.gov NCT07386340 · fetched Nov 12, 2026
- Enhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced FeaturesNA · UNKNOWN · started Oct 20, 2021ClinicalTrials.gov NCT05131139 · fetched Nov 12, 2026
- Eversense® Non-adjunctive Use Post Approval StudyNA · ACTIVE_NOT_RECRUITING · started Apr 13, 2021ClinicalTrials.gov NCT04836546 · fetched Nov 12, 2026
- Post Approval Study of the Eversense® Continuous Glucose MonitoringNA · COMPLETED · started Mar 19, 2019ClinicalTrials.gov NCT03908125 · fetched Nov 12, 2026
- PROMISE Study: An Evaluation of an Implantable Continuous Glucose Sensor up to 180 DaysNA · COMPLETED · started Dec 27, 2018ClinicalTrials.gov NCT03808376 · fetched Nov 12, 2026
- PRECISION Study: Multi-center Study of Performance of a Novel Implanted CGM System Using a Next Generation Transmitter and AlgorithmNA · COMPLETED · started Jul 25, 2017ClinicalTrials.gov NCT03251079 · fetched Nov 12, 2026